Document is current
Any future updates will be listed below
-
Authors
Kolbinger, Fiona R.
Bernard, Vincent
Lee, Jaewon J.
Stephens, Bret M.
Branchi, Vittorio
Raghav, Kanwal P. S.
Maitra, Anirban
Guerrero, Paola A.
Semaan, Alexander
-
Funding
Funding for this research was provided by:
National Institutes of Health (U54CA096300)
National Institutes of Health (T32CA009599)
National Institutes of Health (R01CA218230)
Deutsche Forschungsgemeinschaft (SE-2616/2–1)
- License Information
-
More Information
Article History
Accepted: 8 February 2023
First Online: 2 March 2023
Declarations
:
: A.M. receives royalties for a pancreatic cancer biomarker test from Cosmos Wisdom Biotechnology, and this financial relationship is managed and monitored by the UTMDACC Conflict of Interest Committee. A.M. is also listed as an inventor on a patent that has been licensed by Johns Hopkins University to Thrive Earlier Detection (an Exact Sciences Company). A.M. is a consultant for Freenome and Tezcat. All other authors declare no conflicts of interests.
